ECVAM's activities in promoting the three Rs in the quality control of biologicals

Alternatives to Laboratory Animals

Volumn 32, Issue SUPPL. 1A, 2004, Pages 93-98

  Halder, Marlies ^a,f   Balls, Michael ^b   Hendriksen, Coenraad ^c,d   Cussler, Klaus ^e  

^a ECVAM   (Italy)

^b RUSSELL AND BURCH HOUSE   (United Kingdom)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d NCA   (Netherlands)

^e PAUL EHRLICH INSTITUT   (Germany)

^f JOINT RESEARCH CENTRE   (Italy)

Author keywords

Alternative methods; Biologicals; ECVAM; Prevalidation; Quality control; Three Rs; Validation

Indexed keywords

ANIMAL TESTING ALTERNATIVE; ANIMAL TESTING REDUCTION; ANIMAL TESTING REFINEMENT; ANIMAL TESTING REPLACEMENT; CONFERENCE PAPER; PRIORITY JOURNAL; QUALITY CONTROL; TRAINING; VALIDATION PROCESS;

ANIMALIA;

EID: 3042567736     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290403201s14     Document Type: Conference Paper

References (29)

1. Halder, M., Hendriksen, C., Cussler, K. & Balls, M. (2002). ECVAM's contributions to the implementation of the Three Rs in the production and quality control of biologicals. ATLA 30, 93-108.
2. Weisser, K. & Hechler, U. (1997). Animal welfare aspects in the quality control of immunobiologicals. A critical evaluation of animal tests in pharmacopoeial monographs, 348pp. Nottingham, UK: FRAME for ECVAM and the Paul-Ehrlich-Institut.
3. Hendriksen, C.F.M., Garthoff, B., Aggerbeck, H., Bruckner, L., Castle, P., Cussler, K., Dobbelaer, R., van de Donk, H., van der Gun, J.W., Lefrancois, S., Milstien, J., Minor, P.D., Mougeot, B., Rombaut, B., Ronneberger, H.D., Spieser, J-M., Stolp, R., Straughan, D.W., Tollis, M. & Zigtermans, C. (1994). Alternatives to animal testing in the quality control of immunobiologicals: current status and future prospects. The report and recommendations of ECVAM workshop 4. ATLA 22, 420-434.
4. Garthoff, B., Hendriksen, C., Bayol, A., Goncalves, D., Grauer, A., de Leeuw, R., Noordwijk, J., Pares, M., Pirovano, R., Rieth, M., Ronnebereger, H., Spieser, J-M., Storring, P., Vosbeck, K. & Weichert, H. (1995). Safety and efficacy testing of hormones and related products. The report and recommendations of ECVAM workshop 9. ATLA 23, 699-712.
5. Schade, R., Staak, C., Hendriksen, C., Erhard, M., Hugl, H., Koch, G., Larrson, A., Pollmann, W., van Regenmortel, M., Rijke, E., Spielmann, H., Steinbusch, H. & Straughan, D. (1996). The production of avian (egg yolk) antibodies: IgY. The report and recommendations of ECVAM workshop 21. ATLA 24, 925-934.
6. Marx, U., Embleton, M.J., Fischer, R., Gruber, F.P., Hansson, U., Heuer, J., de Leeuw, W., Logtenberg, T., Merz, W., Portetelle, D., Romette, J-L. & Straughan, D. (1997). Monoclonal antibody production. The report and recommendations of ECVAM workshop 25. ATLA 25, 121-137.
7. Hendriksen, C., Spieser, J-M., Akkermans, A., Balls, M., Bruckner, L., Cussler, K., Daas, A., Descamps, J., Dobbelaer, R., Fentem, J., Halder, M., van der Kamp, M., Lucken, R., Milstien, J., Sesardic, D., Straughan, D. & Valadares, A. (1998). Validation of alternative methods for the potency testing of vaccines. The report and recommendations of ECVAM workshop 31. ATLA 26, 747-761.
8. Leenaars, P.P.A.M., Hendriksen, C.F.M., de Leeuw, W.A., Carat, F., Delahaut, P., Fischer, R., Halder, M., Hanly, W.C., Hartinger, J., Hau, J., Lindblad, E.B., Nicklas, W., Outschoorn, I.M. & Stewart-Tull, D.E.S. (1999). The production of polyclonal antibodies in laboratory animals. The report and recommendations of ECVAM workshop 35. ATLA 27, 79-102.
9. Bruckner, L., Bongers, J., Castle, P., Flore, P.H., Guittet, M., Halder, M., Jungbäck, C., Le Gros, F.X., Tollis, M., Venugopal, K., Wilhelm, M., Zeegers, J. & Zigterman, G. (2000). Three Rs approaches in the production and quality control of avian vaccines. The report and recommendations of ECVAM workshop 41. ATLA 28, 241-258.
10. Hartung, T., Aaberge, I., Berthold, S., Carlin, G., Charton, E., Coecke, S., Fennrich, S., Fischer, M., Gommer, M., Halder, M., Haslov, K., Jahnke, M., Montag-Lessing, T., Poole, S., Schechtman, L., Wendel, A. & Werner-Felmayer, G. (2001). Novel pyrogen tests based on the human fever reaction. The report and recommendations of ECVAM workshop 43. ATLA 29, 99-123.
11. Bruckner, L., Cussler, K. & Halder, M. (2002). Results and recommendation of an ECVAM workshop on alternatives in rabies vaccines quality control. In Program and Abstracts, Fourth World Congress on Alternatives and Animal Use in the Life Sciences, New Orleans, LA, USA, p.74. Alternatives Congress Trust. Website http://www.worldcongress. net/abstract-book/contents.htm (Accessed 4.12.03).
12. Schwanig, M., Nagel, M., Duchow, K. & Krämer, B. (1997). Elimination of abnormal toxicity test for sera and certain vaccines in the European Pharmacopoeia. Vaccine 15, 1047-1048.
13. Charton, E. (1999). Reduction and replacement of animal tests in the European Pharmacopoeia: recent developments for monographs on biological substances. Pharmeuropa 11, 197-199.
14. Hendriksen, C.F.M. (1998). A call for a European prohibition on monoclonal antibody production by the ascites procedure in laboratory animals. ATLA 26, 523-540.
15. Anon. (1998). ECVAM News & Views. ATLA 26, 383-386.
16. Hendriksen, C.F.M., Woltjes, J., Akkermans, A., van der Gun, J.W., Marsman, F.R., Verschure, M.H. & Veldman, K. (1994). Interlaboratory validation of in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use. Biologicals 22, 257-268.
17. Lensing, H.H., Esposito-Farese, M-E., Daas, A. & Spieser, J-M. (2001). Collaborative study for the establishment of two European Pharmacopoeia Biological Reference Preparations for Clostridium tetani antiserum for the serological potency testing of tetanus vaccines for veterinary use. Pharmeuropa Special Issue BIO 2000-2, 43-54.
18. Ebert, E., Öppling, V., Werner, E. & Cussler, K. (1999). Development and prevalidation of two different ELISA systems for the potency testing of Clostridium perfringens beta and epsilon-toxoid containing veterinary vaccines. FEMS Immunology and Medical Microbiology 24, 299-311.
19. Rosskopf-Streicher, U., Johannes, S., Wilhelm, M. & Cussler, K. (2000). Quality control of inactivated erysipelas vaccines: results of an international collaborative study to establish a new regulatory test. Vaccine 19, 1477-1483.
20. ECVAM (2001). Statement on the application of the ELISA procedure for the batch potency testing of tetanus vaccines for human use. ATLA 29, 93-94.
21. ECVAM (2001). Statement on the application of the ToBI test for the batch potency testing of tetanus vaccines for human use. ATLA 29, 94-96.
22. Council of Europe (2002). Assay of tetanus vaccine (absorbed). Pharmeuropa 14, 549-554.
23. Council of Europe (2002). Bovine leptospirosis vaccine (absorbed). Pharmeuropa 14, 666-667.
24. Anon. (2002). ECVAM News & Views. ATLA 30, 485-491.
25. Hendriksen, C.F.M., Steen, B., Visser, J., Cussler, K., Morton, D.B. & Streijger, F. (1999). The evaluation of humane endpoints in pertussis vaccine potency testing. In Humane Endpoints in Animal Experiments for Biomedical Research. Proceedings of the International Conference, 22-25 November 1998, Zeist, The Netherlands (ed. C. Hendriksen & D. Morton). London, UK: The Royal Society of Medicine Press Ltd.
26. The HELP Group (2001). Humane endpoints - lethal parameters: humane endpoints replace lethal parameters in batch potency tests of rabies vaccines. The HELP Group, Bilthoven, The Netherlands. ATLA 29, 503.
27. Storring, P.L., Gaines Das, R.E., Mulders, J.W.M. & Halder, M. (2002). Physiochemical methods for predicting the biological potency of recombinant follicle stimulating hormone: an international collaborative study of isoelectric focusing and capillary zone electrophoresis. Biologicals 30, 217-234.
28. Worth, A. & Balls, M. (2001). The role of ECVAM in promoting the regulatory acceptance of alternative methods in the European Union. ATLA 29, 525-535.
29. Council of Europe (2002). Swine erysipelas vaccine (inactivated). Pharmeuropa 14, 69.